Physician

Chase Andrew Scarbrough, D.O.

According to 2025 Medicare claims, Chase Scarbrough, D.O. (NPI: 1023370913) practices micrographic dermatologic surgery, with the plurality of this provider's patient population coming from Hancock, OH. This provider's primary affiliated billing organization is BLANCHARD VALLEY MEDICAL ASSOCIATES, INC. (NPI: 1407814775; TIN: 34-1148970) and primary practice location at 45840-1332.

Scarbrough's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,051 traditional Medicare patients, billed 4,626 HCPCS/CPT codes, and received $605,835 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 704 prescription claims across 327 beneficiaries totaling $691,712 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 11 records totaling $402. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $83,459 to $605,835. Similarly, Part D prescription costs have risen steadily, from $52,734 to $691,712. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$308K$615K2016 Medicare payment: $83,459 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $122,398 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $298,312 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $607,398 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $473,533 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $615,330 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $524,483 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $458,152 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $605,835 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20163411,411$83,459
20174321,924$122,398
20184511,862$298,312
20198574,359$607,398
20207603,531$473,533
20218234,735$615,330
20228704,132$524,483
20231,0284,485$458,152
20241,0514,626$605,835

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$396K$791K2016 Drug cost: $52,734 (USD; Tot_Drug_Cst)2017 Drug cost: $276,974 (USD; Tot_Drug_Cst)2018 Drug cost: $97,576 (USD; Tot_Drug_Cst)2019 Drug cost: $201,267 (USD; Tot_Drug_Cst)2020 Drug cost: $305,392 (USD; Tot_Drug_Cst)2021 Drug cost: $409,742 (USD; Tot_Drug_Cst)2022 Drug cost: $627,668 (USD; Tot_Drug_Cst)2023 Drug cost: $791,038 (USD; Tot_Drug_Cst)2024 Drug cost: $691,712 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016155303$52,734
2017244532$276,974
2018155271$97,576
2019235450$201,267
2020255518$305,392
2021260526$409,742
2022265552$627,668
2023346727$791,038
2024327704$691,712

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks441561$468
11102Biopsy of related skin growth, first growth137160$56
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more400489$52
17000Destruction of precancer skin growth, 1 growth276324$36
17003Destruction of precancer skin growth, 2-14 growths2231,289$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab22616$225,436
Dupixent PenDupilumab29812$113,049
Dupixent SyringeDupilumab13364$49,699
Triamcinolone AcetonideTriamcinolone Acetonide1505,376$2,032
Clobetasol PropionateClobetasol Propionate321,211$1,318

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$402GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Chase Andrew Scarbrough, D.O.?

Tedicare shows public-source Medicare data for Chase Andrew Scarbrough, D.O. (NPI 1023370913), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chase Andrew Scarbrough, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Chase Andrew Scarbrough, D.O.?

Chase Andrew Scarbrough, D.O. is linked to BLANCHARD VALLEY MEDICAL ASSOCIATES, INC. (billing NPI 1407814775) in the available physician profile data.

Does Chase Andrew Scarbrough, D.O. have Open Payments data?

Chase Andrew Scarbrough, D.O. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.